03/18/2026
Dr. James Bice, a geriatrician from Australia who specializes in dementia care, stopped in Bolivar last week to meet with Dr. Curtis Schreiber and the teams at Missouri Memory Center and CMH Research. Australia has recently approved Kisunla and Leqembi infusion therapy for early stages of Alzheimer's Disease for individuals who have elevated amyloid plaques. Dr. Bice traveled to select sites across the United States to learn more about infusion processes choosing CMH as one of his stops.
During his visit, Dr. Bice spent time in clinic with Dr. Schreiber, connected with our research team, met with our infusion and pharmacy departments and toured the new hospital tower.
Dr. Bice and Dr. Schreiber first connected at the Alzheimer’s Association International Conference in Toronto and have continued collaborating through additional conferences in Australia.
We’re honored to be part of this important international exchange as we continue advancing Alzheimer's care.